287 related articles for article (PubMed ID: 12202965)
41. Antinociceptive and adverse effects of mu- and kappa-opioid receptor agonists: a comparison of morphine and U50488-H.
Gallantine EL; Meert TF
Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):419-27. PubMed ID: 18699797
[TBL] [Abstract][Full Text] [Related]
42. Organizational and activational effects of testosterone on carrageenan-induced inflammatory pain and morphine analgesia.
Borzan J; Fuchs PN
Neuroscience; 2006 Dec; 143(3):885-93. PubMed ID: 17008018
[TBL] [Abstract][Full Text] [Related]
43. Behavioral assessment of temporal summation in the rat: sensitivity to sex, opioids and modulation by NMDA receptor antagonists.
Lomas LM; Picker MJ
Psychopharmacology (Berl); 2005 Jun; 180(1):84-94. PubMed ID: 15696324
[TBL] [Abstract][Full Text] [Related]
44. Estrus phase differences in female rats in morphine antinociception elicited from the ventrolateral periaqueductal gray.
Shane R; Bernal SY; Rozengurtel S; Bodnar RJ
Int J Neurosci; 2007 Jun; 117(6):811-22. PubMed ID: 17454245
[TBL] [Abstract][Full Text] [Related]
45. The counteraction of opioid-induced ventilatory depression by the serotonin 1A-agonist 8-OH-DPAT does not antagonize antinociception in rats in situ and in vivo.
Guenther U; Manzke T; Wrigge H; Dutschmann M; Zinserling J; Putensen C; Hoeft A
Anesth Analg; 2009 Apr; 108(4):1169-76. PubMed ID: 19299781
[TBL] [Abstract][Full Text] [Related]
46. Sex differences in the potency of kappa opioids and mixed-action opioids administered systemically and at the site of inflammation against capsaicin-induced hyperalgesia in rats.
Lomas LM; Barrett AC; Terner JM; Lysle DT; Picker MJ
Psychopharmacology (Berl); 2007 Apr; 191(2):273-85. PubMed ID: 17225166
[TBL] [Abstract][Full Text] [Related]
47. The role of gonadal hormones on opioid receptor protein density in arthritic rats.
Kren MC; Haller VL; Welch SP
Eur J Pharmacol; 2008 Jan; 578(2-3):177-84. PubMed ID: 18054782
[TBL] [Abstract][Full Text] [Related]
48. Sex differences in opioid-mediated pain inhibitory mechanisms during the interphase in the formalin test.
Gaumond I; Spooner MF; Marchand S
Neuroscience; 2007 Apr; 146(1):366-74. PubMed ID: 17306464
[TBL] [Abstract][Full Text] [Related]
49. Sex differences in (-)-pentazocine antinociception: comparison to morphine and spiradoline in four rat strains using a thermal nociceptive assay.
Terner JM; Barrett AC; Cook CD; Picker MJ
Behav Pharmacol; 2003 Feb; 14(1):77-85. PubMed ID: 12576884
[TBL] [Abstract][Full Text] [Related]
50. Differential tolerance to antinociceptive effects of mu opioids during repeated treatment with etonitazene, morphine, or buprenorphine in rats.
Walker EA; Young AM
Psychopharmacology (Berl); 2001 Mar; 154(2):131-42. PubMed ID: 11314675
[TBL] [Abstract][Full Text] [Related]
51. Gender-related differences in the antinociceptive properties of morphine.
Cicero TJ; Nock B; Meyer ER
J Pharmacol Exp Ther; 1996 Nov; 279(2):767-73. PubMed ID: 8930182
[TBL] [Abstract][Full Text] [Related]
52. Antinociceptive effects of cocaine/opioid combinations in rhesus monkeys.
Gatch MB; Negus SS; Butelman ER; Mello NK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1346-54. PubMed ID: 8531102
[TBL] [Abstract][Full Text] [Related]
53. Social and environmental influences on opioid sensitivity in rats: importance of an opioid's relative efficacy at the mu-receptor.
Smith MA; Chisholm KA; Bryant PA; Greene JL; McClean JM; Stoops WW; Yancey DL
Psychopharmacology (Berl); 2005 Aug; 181(1):27-37. PubMed ID: 15778888
[TBL] [Abstract][Full Text] [Related]
54. Sex differences in opioid antinociception: kappa and 'mixed action' agonists.
Craft RM; Bernal SA
Drug Alcohol Depend; 2001 Aug; 63(3):215-28. PubMed ID: 11418226
[TBL] [Abstract][Full Text] [Related]
55. The heritability of antinociception: common pharmacogenetic mediation of five neurochemically distinct analgesics.
Wilson SG; Smith SB; Chesler EJ; Melton KA; Haas JJ; Mitton B; Strasburg K; Hubert L; Rodriguez-Zas SL; Mogil JS
J Pharmacol Exp Ther; 2003 Feb; 304(2):547-59. PubMed ID: 12538806
[TBL] [Abstract][Full Text] [Related]
56. The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor.
Allen RM; Granger AL; Dykstra LA
J Pharmacol Exp Ther; 2003 Nov; 307(2):785-92. PubMed ID: 12975489
[TBL] [Abstract][Full Text] [Related]
57. Gonadal hormones do not alter the development of antinociceptive tolerance to delta-9-tetrahydrocannabinol in adult rats.
Wakley AA; Wiley JL; Craft RM
Pharmacol Biochem Behav; 2015 Jun; 133():111-21. PubMed ID: 25863271
[TBL] [Abstract][Full Text] [Related]
58. Ketamine enhances the efficacy to and delays the development of tolerance to electroacupuncture-induced antinociception in rats.
Huang C; Long H; Shi YS; Han JS; Wan Y
Neurosci Lett; 2005 Feb; 375(2):138-42. PubMed ID: 15670657
[TBL] [Abstract][Full Text] [Related]
59. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. II. A mixed opioid agonist with potent antinociceptive activity and limited effects on respiratory function.
Gengo PJ; Pettit HO; O'Neill SJ; Su YF; McNutt R; Chang KJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):1227-33. PubMed ID: 14534367
[TBL] [Abstract][Full Text] [Related]
60. Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.
Williams J; Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Apr; 584(1):78-86. PubMed ID: 18313663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
